Tagged: clinical trial RSS Toggle Comment Threads | Keyboard Shortcuts

  • NoCamels Team 11:27 am on October 22, 2013 Permalink | Reply
    Tags: clinical trial, , , , transdermal   

    Neuroderm Raising $5M For Transdermal Drug Delivery System Trial 

    Neuroderm Raising $5M For Transdermal Drug Delivery System TrialOctober 22, 2013 | Israeli biomed company Neuroderm, which is developing a transdermal drug delivery system, is in the process of raising $5 million. “Globes” reports that the funds are being raised from current investors and new foreign investors.

    The proceeds will be used to accelerate clinical trials and for a review of a possible IPO on Nasdaq in 2014.

     
  • NoCamels Team 1:20 pm on February 6, 2013 Permalink | Reply
    Tags: , clinical trial, , psoriasis,   

    Can-Fite BioPharma Raises $7.2M In Secondary Offering 

    Can-Fite BioPharma Raises $7.2M In Secondary OfferingIsraeli pharmaceutical company Can-Fite BioPharma Ltd. has announced that it has raised NIS 26.5 million ($7.2 million) in its secondary offering on the Tel Aviv stock exchange. The company says that it will direct the funds towards a phase II/III clinical trial of its psoriasis treatment.

     
  • NoCamels Team 3:02 pm on December 13, 2012 Permalink | Reply
    Tags: capsule, clinical trial, , ,   

    Israeli Pharmaceutical Company Oramed Raises $5.6M 

    Israeli Pharmaceutical Company Oramed Raises $5.6MOramed, and Israeli company which is developing an innovative oral insulin capsule, has announced that it has raised $5.6 million in a private placement. The funds will be used to finance clinical trials of the capsule.

     
  • NoCamels Team 7:53 pm on December 6, 2012 Permalink | Reply
    Tags: clinical trial, elelsyo, ,   

    Protalix Signs $8.3M Deal With Pfizer 

    Protalix Signs $8.3M Deal With PfizerIsraeli pharmaceutical company Protalix has signed a development deal with pharmaceutical giant Pfizer, for the continuation of development of its Elelyso drug. According to the agreement, Portalix will continue to conduct the clinical trials for the drug, which is currently being tested on children and adults. As part of the agreement, the Israeli company will receive up to $8.3 million for milestone achievements.

     
  • NoCamels Team 3:12 pm on November 22, 2012 Permalink | Reply
    Tags: , clinical trial, ,   

    Atox Bio Raising Millions Following Successful Clinical Trial 

    Atox Bio Raising Millions Following Successful Clinical TrialIsraeli company Atox Bio Ltd. has reported a successful clinical trial of its AB103 treatment for Necrotizing Soft-Tissue Infection (NSTI). Financial magazine Globes reports that due to the successful trial, that has shown that the drug was both effective and safe, the company has begun raising millions of dollars. NSTI is a life-threatening bacterial infection with significant morbidity and high mortality rate.

     
  • NoCamels Team 11:09 am on November 18, 2012 Permalink | Reply
    Tags: clinical trial, , glassia, , , type 1   

    Kamada Report Successful Trial On Type 1 Diabetes Treatment 

    Kamada Report Successful Trial On Type 1 Diabetes Treatment Israeli pharmaceutical company Kamada has announced positive results of its Phase I/II clinical trial of the company’s AAT protein, the active ingredient in its drug Glassia. The results indicate that the drug may halt the progression of the disease and enable the pancreas to continue excreting insulin.

     
  • NoCamels Team 12:30 pm on August 7, 2012 Permalink | Reply
    Tags: clinical trial, , muscle regeneration, ,   

    Pluristem Gains Approval For Muscle Regeneration Trial 

    Pluristem - News Flash - IsraelPluristem Therapeutics, a developer of placenta-based cell therapies, announced it has received approval from the Paul-Ehrlich-Institute (PEI), the medical regulatory body in Germany, to commence a Phase I/II study to assess the safety and efficacy of its treatment for the regeneration of injured gluteal musculature following total hip replacement. The Company’s patented PLX (PLacental eXpanded) cells are a drug delivery platform that releases a cocktail of therapeutic proteins in response to a host of local and systemic inflammatory and ischemic diseases. The company is headquartered in Haifa, Israel with offices the US.

     
  • NoCamels Team 3:43 pm on July 24, 2012 Permalink | Reply
    Tags: biopharma, , , clinical trial, , Octreolin   

    Biopharma Co ‘Chiasma’ Closes $38.5M 

    Chiasma - News Flash - IsraelChiasma, a privately held biopharma company, announced that it closed a $38.5 million equity financing co-led by new investor Abingworth and current investor MPM Capital. The round also included investments from existing shareholders. The proceeds will be used complete the phase 3 trial of Octreolin, the company’s proprietary oral form of the peptide octreotide, which is planned to be completed in the second quarter of 2013. Chiasma, based in Jerusalem, is developing oral drugs that previously were only available by injection, thereby providing patients with pain-free medications that are self-administered.

     

     
  • NoCamels Team 7:58 am on May 30, 2012 Permalink | Reply
    Tags: clinical trial, , IntelGenx, , , RHB-103   

    ‘RedHill’ Announces Successful Clinical Trial Of Migraine Treatment 

    RedHill Logo - News Flash - IsraelRedHill Biopharma, an Israeli biopharmaceutical company announced positive results in a clinical trial with RHB-103, an oral thin-film formulation of Rizatriptan for the treatment of acute migraine. According to the company, the trial, which was conducted in Canada, met its specified endpoints and FDA’s criteria. RedHill focuses primarily on development of late clinical-stage, patent protected, new formulations and combinations of existing drugs. It is developing RHB-103 with its Canadian co-development partner IntelGenx. The company is targeting a segment of the migraine market – namely the family of triptan migraine drugs – estimated at approximately $2 billion in 2011.

     
c
compose new post
j
next post/next comment
k
previous post/previous comment
r
reply
e
edit
o
show/hide comments
t
go to top
l
go to login
h
show/hide help
shift + esc
cancel
nike tn 2016 louboutin pas cher louboutin pas cher louboutin pas cher louboutin pas cher louboutin pas cher hogan outlet hogan outlet online outlet hogan hogan outlet outlet hogan hogan outlet online moncler outlet online moncler outlet moncler outlet moncler outlet online moncler outlet woolrich outlet online woolrich outlet online woolrich outlet online hair extensions hair extensions clip in hair extensions clip in hair extensions clip in human hair extensions clip in human hair extensions hair extensions uk hair extensions uk hair extensions uk clip in hair extensions uk clip in hair extensions uk clip in hair extensions uk